0.56
+0.0128(+2.34%)
Currency In USD
| Previous Close | 0.55 |
| Open | 0.55 |
| Day High | 0.59 |
| Day Low | 0.54 |
| 52-Week High | 2.5 |
| 52-Week Low | 0.22 |
| Volume | 1.79M |
| Average Volume | 6.32M |
| Market Cap | 23.25M |
| PE | -0.24 |
| EPS | -2.33 |
| Moving Average 50 Days | 0.39 |
| Moving Average 200 Days | 0.41 |
| Change | 0.01 |
If you invested $1000 in ProPhase Labs, Inc. (PRPH) 10 years ago, it would be worth $341.22 as of October 04, 2025 at a share price of $0.56. Whereas If you bought $1000 worth of ProPhase Labs, Inc. (PRPH) shares 5 years ago, it would be worth $185.3 as of October 04, 2025 at a share price of $0.56.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE
GlobeNewswire Inc.
Sep 23, 2025 12:00 PM GMT
COVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products co
ProPhase Continues its Exploration of a Crypto Treasury Strategy
GlobeNewswire Inc.
Sep 22, 2025 12:00 PM GMT
UNIONDALE, NY, Sept. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, announced that the Company entered into an agreement relating to
ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor
GlobeNewswire Inc.
Sep 12, 2025 12:00 PM GMT
ProPhase Labs Stockholders Deliver Strong Mandate at Special Meeting UNIONDALE, NY, Sept. 12, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products compa